We are Committed to Life

In Q3/26, Fresenius continued to build on the structural improvements from its #FutureFresenius transformation, delivering healthy organic revenue growth, double-digit Core EPS growth while further improving returns. The company’s Growth Vectors continued to gain share, while the hospital business sustained resilient growth. Based on the upgraded core and the increased strategic flexibility, Fresenius started to scale its Biopharma business through targeted investments.

• 中国首个获批的特殊医学用途高能量密度全营养配方食品，实现我国该类特医产品零的突破 • 能量密度达2.0 kcal/mL，为有高能量需求和（或）液体摄入受限的人群带来新的全营养配方选择 • 由费卡华瑞开发，体现费森尤斯卡比持续将全球营养科学积累与中国临床需求相结合的努力

8月18日，江苏省副省长赵岩在南京会见费森尤斯卡比亚太区执行副总裁Ulf Jansson一行。双方围绕费森尤斯卡比在江苏的发展，以及进一步深化医药健康领域合作进行了交流。